TPG Valuation

Is B81 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of B81 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: B81 (€62) is trading above our estimate of fair value (€14.84)

Significantly Below Fair Value: B81 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for B81?

Key metric: As B81 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for B81. This is calculated by dividing B81's market cap by their current revenue.
What is B81's PS Ratio?
PS Ratio2x
SalesUS$3.41b
Market CapUS$24.11b

Price to Sales Ratio vs Peers

How does B81's PS Ratio compare to its peers?

The above table shows the PS ratio for B81 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2x
DWS DWS Group GmbH KGaA
2x-4.3%€8.0b
MLP MLP
0.6x2.3%€673.3m
DBAN Deutsche Beteiligungs
4.1x23.1%€445.9m
DBK Deutsche Bank
1.2x4.2%€32.8b
B81 TPG
2x-4.2%€24.1b

Price-To-Sales vs Peers: B81 is good value based on its Price-To-Sales Ratio (2x) compared to the peer average (2x).


Price to Sales Ratio vs Industry

How does B81's PS Ratio compare vs other companies in the DE Capital Markets Industry?

25 CompaniesPrice / SalesEstimated GrowthMarket Cap
DBK Deutsche Bank
1.2x4.2%US$33.99b
MLP MLP
0.6x2.3%US$697.91m
MUX Mutares SE KGaA
0.1x10.8%US$568.77m
AR4 AURELIUS Equity Opportunities SE KGaA
0.2x0.01%US$500.05m
B81 2.0xIndustry Avg. 2.8xNo. of Companies25PS0612182430+
25 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: B81 is good value based on its Price-To-Sales Ratio (2x) compared to the German Capital Markets industry average (2.8x).


Price to Sales Ratio vs Fair Ratio

What is B81's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

B81 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2x
Fair PS Ratio3.1x

Price-To-Sales vs Fair Ratio: B81 is good value based on its Price-To-Sales Ratio (2x) compared to the estimated Fair Price-To-Sales Ratio (3.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst B81 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€62.00
€68.35
+10.2%
11.7%€82.79€53.91n/a14
Jan ’26€60.00
€67.98
+13.3%
11.6%€82.42€53.67n/a14
Dec ’25€64.50
€62.40
-3.3%
10.1%€72.88€53.00n/a14
Nov ’25€61.00
€56.23
-7.8%
12.4%€67.05€41.33n/a14
Oct ’25€50.50
€46.70
-7.5%
12.9%€56.58€38.62n/a14
Sep ’25€43.80
€44.92
+2.5%
11.0%€56.68€38.69n/a13
Aug ’25€46.20
€44.13
-4.5%
10.7%€55.16€36.77n/a13
Jul ’25€37.80
€44.20
+16.9%
7.2%€49.36€40.05n/a13
Jun ’25€37.60
€44.07
+17.2%
7.3%€49.13€39.86n/a13
May ’25€40.00
€44.45
+11.1%
7.7%€50.73€40.40n/a13
Apr ’25€40.60
€42.39
+4.4%
6.7%€47.92€38.71n/a14
Mar ’25€40.20
€42.39
+5.5%
6.7%€47.92€38.71n/a14
Feb ’25€39.20
€38.07
-2.9%
9.6%€44.11€33.08n/a14
Jan ’25€38.60
€32.69
-15.3%
11.8%€41.22€28.40€60.0013
Dec ’24€31.40
€31.29
-0.3%
10.1%€39.19€27.34€64.5012
Nov ’24€25.60
€30.45
+18.9%
4.2%€32.10€28.33€61.0012
Oct ’24€28.20
€30.46
+8.0%
6.3%€33.32€26.65€50.5012
Sep ’24€26.00
€29.18
+12.2%
6.5%€32.08€25.66€43.8012
Aug ’24€26.20
€29.69
+13.3%
7.3%€33.93€25.89€46.2012
Jul ’24€27.00
€30.14
+11.6%
11.9%€36.36€25.17€37.8012
Jun ’24€23.60
€30.14
+27.7%
11.9%€36.36€25.17€37.6012
May ’24€25.40
€30.79
+21.2%
9.2%€36.22€27.17€40.0013
Apr ’24€25.40
€32.80
+29.1%
11.3%€39.64€27.66€40.6013
Mar ’24€30.40
€33.71
+10.9%
10.9%€40.57€28.30€40.2013
Feb ’24€29.00
€32.85
+13.3%
11.8%€40.32€27.49€39.2013
Jan ’24€25.80
€34.77
+34.8%
13.4%€45.25€28.28€38.6013

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 04:50
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TPG Inc. is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James FotheringhamBMO Capital Markets Equity Research
Rufus HoneBMO Capital Markets Equity Research
Etienne RicardBMO Capital Markets Equity Research